GP
Giles Richard Platford (President, IBU) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $1.2M of TAK (55,617 sh × $20.90, as filed), executed Nov 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.7M
shares × price, as filed
Last traded
Nov 4
Filed Nov 5
Median ADV $57.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
TAKRecent filings
TAKSALE
Takeda Pharmaceutical Company Limited
View filing →
$1.2M55,617 sh × $20.90
Exec Nov 4
Filed Nov 5 · 3:54 PM ET TAKSALE Takeda Pharmaceutical Company Limited View filing → $532K
31,083 sh × $17.10
Exec Aug 10
Filed Aug 12 · 9:25 PM ET